acquired
Stage
2017
Founded
2
Investors
About
VectivBio was a clinical-stage biopharmaceutical company focused on developing innovative treatments for severe rare conditions, notably apraglutide for short bowel syndrome.
Explore VectivBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.